BioCryst Pharmaceuticals (BCRX) Reports Break-Even Earnings for Q1

BioCryst Pharmaceuticals (BCRX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of$0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this drugmaker would post a loss of $0.06 per share when it actually produced a loss of$0.13, delivering a surprise of -116.67%.Over the last four quarters, the company ha ...